Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240328312304/en/
Figure 1: Anterior inferior tibiofibular ligament (“AITFL”) Repair Showing the Grappler® R3INFORCE™ Dynamic Anchor (left) and Grappler® Knotless Anchor (center). Complete Extraosseous Repair with Grappler® R3INFORCE™ System shown on right. (Graphic: Business Wire)
Upon determination of syndesmotic instability, the Grappler® R3INFORCE™ Anchors are placed in plate holes or other anatomic locations where pre-loaded suture tape can be routed and tensioned to address the injured ligament or ligaments. The Dynamic Anchor allows for micromotion in the repair to better replicate the mechanics of the native tissue.
This system is highly synergistic with Paragon 28’s existing offerings and can utilize the recently launched Grappler® Knotless Sutures. This compatibility allows for multiple configurations for surgeons to cater their syndesmotic repair to their own treatment philosophies.
The Grappler® R3INFORCE™ Extraosseous Repair System is sterile packed and includes all instrumentation needed to complete the case in multiple configurations, reducing waste and intraoperative complexity.
Paragon 28’s CEO,
Surgeon Designer
The Grappler® R3INFORCE™ Extraosseous Repair System bolsters Paragon 28’s soft tissue offering, which includes the Paratrooper™ Plantar Plate System, TenoTac™ 2.0 Soft Tissue Fixation System, Grappler® Interference Screw System, Grappler® Suture Anchor System, Grappler® Knotless Anchor System, Bridgeline™ Tape, R3ACT® Stabilization System, R3LEASE™ Stabilization System, and Mister Tendon™ Harvester. With this comprehensive portfolio,
About
Based in
Forward Looking Statements
Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Paragon 28’s potential to shape a better future for foot and ankle patients. You are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are only predictions based on our current expectations, estimates, and assumptions, valid only as of the date they are made, and subject to risks and uncertainties, some of which we are not currently aware. Forward‐looking statements should not be read as a guarantee of future performance or results and may not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. These forward‐looking statements are based on Paragon 28’s current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward‐looking statements as a result of these risks and uncertainties. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Paragon 28’s business in general, see Paragon 28’s current and future reports filed with the
Disclaimer
Nothing in this material is intended to provide specific medical advice or to take the place of written law or regulations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240328312304/en/
Investor Contact
Senior Vice President, Strategy and Investor Relations
Phone: (720) 912-1332
Source: